Relapsed Leukemia

8 registered clinical trials studyying Relapsed Leukemia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia NCT07297173	Beijing 302 Hospital	Phase 1
Recruiting	Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) NCT06644183	Jennifer R. Brown, MD, PhD	Phase 1 / Phase 2
Withdrawn	Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory L NCT05321940	Juan C. Ramos, MD	Phase 1
Unknown	Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemi NCT05519384	Institute of Hematology & Blood Diseases Hospital, China	EARLY_Phase 1
Unknown	Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph NCT05495035	Institute of Hematology & Blood Diseases Hospital, China	Phase 1
Completed	Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children NCT02512926	Stanford University	Phase 1
Completed	Pharmacokinetic Studies Participation Survey NCT00923468	National Cancer Institute (NCI)	—
Completed	A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. NCT00315705	Genzyme, a Sanofi Company	Phase 1 / Phase 2